Quantification of Human Adipogenesis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01257997

Enrollment

Registered

2010-12-10

Start date

2010-12-31

Completion date

2017-01-31

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

No specific experimental conditions

Brief summary

This pilot study is using a novel technology to measure the rate of turnover of new fat cells. Analysis of volunteer samples is ongoing, however the study is currently not enrolling new volunteers.

Interventions

BIOLOGICAL15N-Thymidine, 2H-Water

Stable isotope 15N-thymidine, infused IV (15mg/hour) for 72 hours (phase 1 pilot). Stable isotope 2H-water, ingested by mouth once per day for 3 days (phase 1 pilot) or 28 days (phase 2 pilot).

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 49 Years

Healthy volunteers

Yes

Inclusion criteria

* Aged 18-49 years. * Healthy.

Exclusion criteria

* Significant chronic medical illness. * Illicit substance or alcohol abuse. * Body mass index \> 27 kg/meters squared. * Underweight (BMI \< 20 kg/m2). * History of keloid formation (excessive scarring). * Pregnant.

Design outcomes

Primary

Measure	Time frame
Quantifying human adipogenesis-counting the number of new fat cells.	4 weeks-7 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026